A team of amateur cyclists, including former blood cancer patients, is riding the full Tour de France route to raise £1 million [1] for Cure Leukaemia.
The initiative highlights the physical recovery and resilience of cancer survivors while raising critical funds for blood cancer research and patient care. The effort is supported by a partnership with Flutter Entertainment.
The journey began in Barcelona and is scheduled to conclude on the Champs-Élysées in Paris. The riders are traversing a distance between 3,333 km [1] and 3,338 km [2] over a period of 21 days [2]. This timeline coincides with the 113th Tour de France, which runs from July 4 to July 26, 2026 [3].
To document the challenge, the team is featured in a three-part docuseries titled “Riding for Survival” [1]. The series follows the participants as they navigate the 21 stages [3] of the professional race's route. The fundraising goal is approximately $1.36 million [2], intended to support the Cure Leukaemia charity.
The ride serves as a symbolic parallel to the professional race. While the elite cyclists compete for a title, these amateurs are cycling to secure the health and future of blood cancer patients. The distance covered is one of the most grueling challenges in amateur cycling, requiring immense endurance from participants who have previously battled life-threatening illnesses.
“Former blood cancer patients are riding the full Tour de France route to raise £1 million.”
This campaign leverages the global visibility of the Tour de France to bring attention to blood cancer survival. By pairing a high-profile athletic event with a medical charity, the organizers are using 'extreme endurance' as a metaphor for the long-term struggle of cancer recovery, potentially increasing donor engagement through a narrative of survival and triumph.
